SCHEMBL19638003

SCHEMBL19638003

CCCCC(=O)Nc1cccc(C(F)(F)F)c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C19 P33261 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP2C9 P11712 1/20 0.54
MEN1 O00255 1/20 0.54
CYP2D6 P10635 1/20 0.54
RXFP1 Q9HBX9 1/20 0.53
CETP P11597 2/20 0.52
ALDH1A1 P00352 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11616583 0.87 ALDH1A1 (0.67) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL27727085 0.84 PLK1 (0.61) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL6017228 0.83 POLB (0.63) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL4145745 0.82 GAA (0.62) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL7932218 0.81 TAS2R14 (0.52) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL10713482 0.81 CETP (0.54) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL31554540 0.79 TAS2R14 (0.50) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL11067319 0.79 TAS2R14 (0.63) KMT2AMEN1ALDH1A1HDAC6POLB
SCHEMBL7505420 0.78 ALDH1A1 (0.74) CYP1A2CYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL985910 0.77 TAS2R14 (0.57) CYP1A2KMT2AMEN1RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11338004-B2 Composition for preventing or treating cranial nerve disease comprising fomes fomentarius extract, fraction thereof, or compound isolated therefrom as active ingredient DONG-EUI UNIVERSITY INDUSTRIAL-ACADEMIC COOPERATION FOUNDATION (KR) 2022-05-24 US claimed
WO-2025080981-A1 TEMPERATURE INDICATION LABELS MICROTEK LABORATORIES, INC. (US) 2025-04-17 WO disclosed
US-20250123158-A1 TEMPERATURE INDICATION LABELS MICROTEK LABORATORIES, INC. (US) 2025-04-17 US disclosed
CN-113292128-B Apparatus and method for desalting water by thermal deionization and liquid phase ion extraction 艾迪奥尼克斯公司 2024-07-05 CN disclosed
CN-118103484-A Process for producing high purity aromatics from mixed aromatic feed streams 维仁特公司 2024-05-28 CN disclosed
US-20230382775-A1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION ADIONICS (FR) 2023-11-30 US disclosed
US-11772997-B2 Method for extracting salts and temperature-regenerated extracting composition ADIONICS (FR) 2023-10-03 US disclosed
US-11731933-B2 Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid ADIONICS (FR) 2023-08-22 US disclosed
US-11338004-B2 Composition for preventing or treating cranial nerve disease comprising fomes fomentarius extract, fraction thereof, or compound isolated therefrom as active ingredient DONG-EUI UNIVERSITY INDUSTRIAL-ACADEMIC COOPERATION FOUNDATION (KR) 2022-05-24 US disclosed
CN-109641160-B Method for extracting salt and temperature-regenerated extraction composition 艾迪奥尼克斯公司 2022-02-25 CN disclosed
US-20210355076-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2021-11-18 US disclosed
CN-113292128-A Apparatus and method for desalination of water by thermal deionization and liquid phase ion extraction 艾迪奥尼克斯公司 2021-08-24 CN disclosed
US-11066356-B2 Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid ADIONICS (FR) 2021-07-20 US disclosed
US-20210214254-A1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION ADIONICS (FR) 2021-07-15 US disclosed
CN-107207288-B Apparatus and method for desalination of water by thermal deionization and liquid phase ion extraction 艾迪奥尼克斯公司 2021-07-06 CN disclosed
EP-3808425-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2021-04-21 EP disclosed
EP-3487597-A1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION Adionics (FR) 2019-05-29 EP disclosed
CN-109641160-A Extract the method for salt and the extracts composition of temperature regeneration 艾迪奥尼克斯公司 2019-04-16 CN disclosed
US-20180009738-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2018-01-11 US disclosed
EP-3247677-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731933-B2 Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid AQP3, AQP1, AQP4 CYP1A2 4043/4885CYP3A4 4048/4885CYP2C19 3157/4885
US-20210355076-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID AQP3, AQP1, AQP4 CYP1A2 4043/4885CYP3A4 4048/4885CYP2C19 3157/4885
US-20180009738-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID AQP3, AQP1, AQP4 CYP1A2 4043/4885CYP3A4 4048/4885CYP2C19 3157/4885
US-11066356-B2 Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid AQP3, AQP1, AQP4 CYP1A2 4043/4885CYP3A4 4048/4885CYP2C19 3157/4885
US-11338004-B2 Composition for preventing or treating cranial nerve disease comprising fomes fomentarius extract, fraction thereof, or compound isolated therefrom as active ingredient NEFM, FABP7, NGF CYP1A2 2452/4885CYP3A4 3182/4885CYP2C19 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.